Literature DB >> 22624734

Psychosocial and psychiatric characteristics of suicide completers with psychiatric treatment before death: a psychological autopsy study of 76 cases.

Seiko Hirokawa1, Toshihiko Matsumoto, Yotaro Katsumata, Masahiko Kitani, Masato Akazawa, Yoshitomo Takahashi, Norito Kawakami, Naoki Watanabe, Masami Hirayama, Akiko Kameyama, Tadashi Takeshima.   

Abstract

AIM: The present study was conducted to examine differences in psychosocial and psychiatric characteristics between suicide completers with and without a history of psychiatric treatment within the year before death, using a psychological autopsy method.
METHODS: A semi-structured interview was administered by a psychiatrist and other mental health professionals for the closest bereaved of 76 suicide completers.
RESULTS: Suicide completers with a history of psychiatric treatment (n = 38) were significantly younger than those without (n = 38) (P < 0.01), and a significantly higher proportion of cases in the treatment group were estimated to be suffering from schizophrenia. Further, in 57.9% of the treatment group, the fatal suicidal behavior involved overdose with prescribed psychotropic drugs. In addition, female suicide completers in the treatment group were more likely to have a history of self-harm or non-fatal suicidal behavior.
CONCLUSION: Many suicide completers who received psychiatric treatment were young adults. It was common for suicide completers to overdose on prescribed drugs as a supplementary means of suicide, and many experienced self-harming behavior before death. In addition, a higher proportion of the treatment cases suffered from schizophrenia.
© 2012 The Authors. Psychiatry and Clinical Neurosciences © 2012 Japanese Society of Psychiatry and Neurology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22624734     DOI: 10.1111/j.1440-1819.2012.02343.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  7 in total

Review 1.  Negotiating the maze: risk factors for suicidal behavior in chronic pain patients.

Authors:  Toby R O Newton-John
Journal:  Curr Pain Headache Rep       Date:  2014-09

2.  Usefulness of an educational lecture focusing on improvement in public awareness of and attitudes toward depression and its treatments.

Authors:  Takashi Yakushi; Teizo Kuba; Yuzuru Nakamoto; Hiroshi Fukuhara; Munenaga Koda; Osamu Tanaka; Tsuyoshi Kondo
Journal:  BMC Health Serv Res       Date:  2017-02-10       Impact factor: 2.655

3.  Possible factors influencing the duration of hospital stay in patients with psychiatric disorders attempting suicide by jumping.

Authors:  Tsubasa Omi; Hiroshi Ito; Keisen Riku; Koji Kanai; Hiromune Takada; Satoshi Fujimi; Hidenori Matsunaga; Kazutaka Ohi
Journal:  BMC Psychiatry       Date:  2017-03-20       Impact factor: 3.630

4.  Analysis of psychotropic drug-related deaths in south Osaka.

Authors:  Naoto Tani; Tomoya Ikeda; Tomomi Michiue; Shigeki Oritani; Fumiya Morioka; Takaki Ishikawa
Journal:  Subst Abuse Rehabil       Date:  2018-09-24

5.  Suicide decline and improved psychiatric treatment status: longitudinal survey of suicides and serious suicide attempters in Tokyo.

Authors:  Yasushi Otaka; Ryosuke Arakawa; Ryuichiro Narishige; Yoshiro Okubo; Amane Tateno
Journal:  BMC Psychiatry       Date:  2022-03-29       Impact factor: 3.630

6.  A comparison of the characteristics of suicide attempters with and without psychiatric consultation before their suicidal behaviours: a cross-sectional study.

Authors:  Kohei Harada; Nobuaki Eto; Yoko Honda; Naoko Kawano; Yuma Ogushi; Mayuko Matsuo; Ryoji Nishimura
Journal:  BMC Psychiatry       Date:  2014-05-21       Impact factor: 3.630

7.  Pulverizing medication as a harm reduction and intentional drug overdose prevention strategy: Two case studies.

Authors:  Keisuke Takanobu; Daisuke Okazaki; Shinya Watanabe; Nobuyuki Mitsui; Teruaki Tanaka
Journal:  Neuropsychopharmacol Rep       Date:  2021-06-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.